BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28283963)

  • 1. The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries.
    Sarkis GA; Mangaonkar MD; Moghieb A; Lelling B; Guertin M; Yadikar H; Yang Z; Kobeissy F; Wang KK
    Curr Neurol Neurosci Rep; 2017 Mar; 17(3):23. PubMed ID: 28283963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application.
    Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Ghandour H; Mondello S; Kobeissy F
    Methods Mol Biol; 2016; 1462():157-74. PubMed ID: 27604718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroproteomics in neurotrauma.
    Ottens AK; Kobeissy FH; Golden EC; Zhang Z; Haskins WE; Chen SS; Hayes RL; Wang KK; Denslow ND
    Mass Spectrom Rev; 2006; 25(3):380-408. PubMed ID: 16498609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Factors and Protein Biomarkers as Target Therapeutics in Traumatic Spinal Cord and Brain Injury.
    Kumar S; Fritz Z; Sulakhiya K; Theis T; Berthiaume F
    Curr Neuropharmacol; 2020; 18(11):1092-1105. PubMed ID: 32442086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury.
    Moghieb A; Bramlett HM; Das JH; Yang Z; Selig T; Yost RA; Wang MS; Dietrich WD; Wang KK
    Mol Cell Proteomics; 2016 Jul; 15(7):2379-95. PubMed ID: 27150525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in Neurotrauma: Good, Bad, or Dysregulated.
    Wu J; Lipinski MM
    Cells; 2019 Jul; 8(7):. PubMed ID: 31295858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of biomarkers of traumatic brain injury.
    Wang KK; Ottens AK; Liu MC; Lewis SB; Meegan C; Oli MW; Tortella FC; Hayes RL
    Expert Rev Proteomics; 2005 Aug; 2(4):603-14. PubMed ID: 16097892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofluid Proteomics and Biomarkers in Traumatic Brain Injury.
    Azar S; Hasan A; Younes R; Najdi F; Baki L; Ghazale H; Kobeissy FH; Zibara K; Mondello S
    Methods Mol Biol; 2017; 1598():45-63. PubMed ID: 28508357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel neuroproteomic approaches to studying traumatic brain injury.
    Ottens AK; Kobeissy FH; Fuller BF; Liu MC; Oli MW; Hayes RL; Wang KK
    Prog Brain Res; 2007; 161():401-18. PubMed ID: 17618994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroproteomics Studies: Challenges and Updates.
    Ramadan N; Ghazale H; El-Sayyad M; El-Haress M; Kobeissy FH
    Methods Mol Biol; 2017; 1598():3-19. PubMed ID: 28508355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord injury and co-occurring traumatic brain injury: assessment and incidence.
    Macciocchi S; Seel RT; Thompson N; Byams R; Bowman B
    Arch Phys Med Rehabil; 2008 Jul; 89(7):1350-7. PubMed ID: 18586138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and bioinformatic analyses of spinal cord injury‑induced skeletal muscle atrophy in rats.
    Wei ZJ; Zhou XH; Fan BY; Lin W; Ren YM; Feng SQ
    Mol Med Rep; 2016 Jul; 14(1):165-74. PubMed ID: 27177391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of proteomics technology to the field of neurotrauma.
    Denslow N; Michel ME; Temple MD; Hsu CY; Saatman K; Hayes RL
    J Neurotrauma; 2003 May; 20(5):401-7. PubMed ID: 12803973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics analysis after traumatic brain injury in rats: the search for potential biomarkers.
    Ding J; Ding Z; Yuan F; Guo J; Chen H; Gao W; Wang R; Gu Y; Chen J; Guo Y; Tian H
    Arq Neuropsiquiatr; 2015 Apr; 73(4):342-9. PubMed ID: 25992526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traumatic brain injury in U.S. Veterans with traumatic spinal cord injury.
    Creasey GH; Lateva ZC; Schüssler-Fiorenza Rose SM; Rose J
    J Rehabil Res Dev; 2015; 52(6):669-76. PubMed ID: 26562623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.
    Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I
    Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury.
    Nielson JL; Paquette J; Liu AW; Guandique CF; Tovar CA; Inoue T; Irvine KA; Gensel JC; Kloke J; Petrossian TC; Lum PY; Carlsson GE; Manley GT; Young W; Beattie MS; Bresnahan JC; Ferguson AR
    Nat Commun; 2015 Oct; 6():8581. PubMed ID: 26466022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed Quantitative Proteomics Reveals Proteomic Alterations in Two Rodent Traumatic Brain Injury Models.
    Park J; Lee SH; Shin D; Kim Y; Kim YS; Seong MY; Lee JJ; Seo HG; Cho WS; Ro YS; Kim Y; Oh BM
    J Proteome Res; 2024 Jan; 23(1):249-263. PubMed ID: 38064581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of published research about the acute care and rehabilitation of traumatic brain injured and spinal cord injured patients.
    Bragge P; Chau M; Pitt VJ; Bayley MT; Eng JJ; Teasell RW; Wolfe DL; Gruen RL
    J Neurotrauma; 2012 May; 29(8):1539-47. PubMed ID: 22191665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
    Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
    PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.